References
1. World Health Organization. Coronavirus disease 2019 (COVID-19)
Situation Report – 51. March 2020.
https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf.
Accessed May 21, 2020.
2. Yang W, Cao Q, Qin L, et al. Clinical characteristics and imaging
manifestations of the 2019 novel coronavirus disease (COVID-19):A
multi-center study in Wenzhou city, Zhejiang, China. J Infect. 2020; 80:
388-393.
3. People Who Are at Higher Risk for Severe Illness |
Coronavirus | COVID-19 | CDC.
https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/groups-at-higher-risk.html.
Accessed May 21, 2020.
4. Coronavirus Disease 2019 (COVID-19) Frequently Asked Questions
| FDA.
https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/coronavirus-disease-2019-covid-19-frequently-asked-questions.
Accessed May 21, 2020.
5. Becker RC. Covid‑19 treatment update: follow the scientific evidence.
J Thromb Thrombolysis. 2020. [Epub ahead of print].
6. The hunt for an effective treatment for COVID-19 | Feature
| Pharmaceutical Journal.
https://www.pharmaceutical-journal.com/news-and-analysis/features/the-hunt-for-an-effective-treatment-for-covid-19/20207883.article?firstPass=false.
Accessed May 21, 2020.
7. Solidarity clinical trial for COVID-19 treatments.
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments.
Accessed April 26, 2020.
8. Drug Interaction Concerns for COVID-19 Treatments | Clinical
Drug Information.
https://www.wolterskluwercdi.com/blog/drug-interaction-concerns-covid-19-treatments/.
Accessed April 28, 2020.
9. Back D, Marzolini C, Hodge C, et al. COVID-19 treatment in patients
with comorbidities: Awareness of drug-drug interaction. Br J Clin
Pharmacol. [Epub ahead of print].
10. Liverpool COVID-19 Interactions.
https://www.covid19-druginteractions.org/. Accessed April 28, 2020.
11. Lexi-Interact Data Fields.
http://webstore.lexi.com/Information/Product-Information/Lexi-Interact-Fields.
Accessed May 14, 2020.
12. Farzanegan B, Alehashem M, Bastani M, Baniasadi S. Potential
drug-drug interactions in cardiothoracic intensive care unit of a
pulmonary teaching hospital. J Clin Pharmacol. 2015; 55: 132-136.
13. Hassanzad M, Tashayoie Nejad S, Mahboobipour AA, Salem F, Baniasadi
S. Potential drug-drug interactions in hospitalized pediatric patients
with respiratory disorders: A retrospective review of clinically
important interactions. Drug Metab Pers Ther. 2020: 35.
14. Croxtall JD, Perry CM. LopinavirRitonavir: A review of its use in
the management of HIV-1 infection. Drugs. 2010; 70: 1885-1915.
15. Chu CM, Cheng VCC, Hung IFN, et al. Role of lopinavir/ritonavir in
the treatment of SARS: Initial virological and clinical findings.
Thorax. 2004; 59: 252-256.
16. Chan JFW, Yao Y, Yeung ML, et al. Treatment with lopinavir/ritonavir
or interferon-β1b improves outcome of MERSCoV infection in a nonhuman
primate model of common marmoset. J Infect Dis. 2015; 212: 1904-1913.
17. Hung IF, Lung K, Tso EY, et al. Articles Triple combination of
interferon beta-1b , lopinavir – ritonavir , and ribavirin in the
treatment of patients admitted to hospital with COVID-19 : an
open-label , randomised , phase 2 trial. Lancet. 2020; 6736: 1-10.
18. Lopinavir and Ritonavir - Atorvastatin. Interactions. Lexicomp.
Wolters Kluwer Health, Inc. Riverwoods, IL. Available at:
http://online.lexi.com. Accessed April 30 2020.
19. Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and
challenges. Lancet Gastroenterol Hepatol. 2020; 5: 428-430.
20. Lopinavir and Ritonavir - Rosuvastatin. Interactions. Lexicomp.
Wolters Kluwer Health, Inc. Riverwoods, IL. Available at:
http://online.lexi.com. Accessed April 30 2020.
21. Mah Ming JB, Gill MJ. Drug-induced rhabdomyolysis after concomitant
use of clarithromycin, atorvastatin, and lopinavir/ritonavir in a
patient with HIV. AIDS Patient Care STDS. 2003; 17: 207‐210.
22. De Kanter CT, Keuter M, Van Der Lee MJ, Koopmans PP, Burger DM.
Rhabdomyolysis in an HIV-infected patient with impaired renal function
concomitantly treated with rosuvastatin and lopinavir/ritonavir. Antivir
Ther. 2011; 16: 435-437.
23. Lopinavir and Ritonavir - Alprazolam. Interactions. Lexicomp.
Wolters Kluwer Health, Inc. Riverwoods, IL. Available at:
http://online.lexi.com. Accessed April 30 2020.
24. Jenh Hsu A, Carson KA, Yung R, Paul A. Severe prolonged sedation
associated with coadministration of protease inhibitors and intravenous
midazolam during bronchoscopy. Pharmacotherapy. 2012; 32: 538-545.
25. Lopinavir and Ritonavir - Midazolam. Interactions. Lexicomp. Wolters
Kluwer Health, Inc. Riverwoods, IL. Available at:
http://online.lexi.com. Accessed April 30 2020.
26. Backman ES, Triant VA, Ehrenfeld JM, et al. Safety of midazolam for
sedation of HIV-positive patients undergoing colonoscopy. HIV Med. 2013;
14: 379-384.
27. Clerkin KJ, Fried JA, Raikhelkar J, et al. Coronavirus Disease 2019
(COVID-19) and Cardiovascular Disease. Circulation. 2020. [Epub ahead
of print].
28. Lopinavir and Ritonavir - Diltiazem. Interactions. Lexicomp. Wolters
Kluwer Health, Inc. Riverwoods, IL. Available at:
http://online.lexi.com. Accessed April 30 2020.
29. Kirby BJ, Collier AC, Kharasch ED, Whittington D, Thummel KE,
Unadkat JD. Complex drug interactions of the HIV protease inhibitors 3:
Effect of simultaneous or staggered dosing of digoxin and ritonavir,
nelfinavir, rifampin, or bupropion. Drug Metab Dispos. 2012; 40:
610-616.
30. Lopinavir and Ritonavir - Digoxin. Interactions. Lexicomp. Wolters
Kluwer Health, Inc. Riverwoods, IL. Available at:
http://online.lexi.com. Accessed April 30 2020.
31. Lopinavir and Ritonavir - Amiodarone. Interactions. Lexicomp.
Wolters Kluwer Health, Inc. Riverwoods, IL. Available at:
http://online.lexi.com. Accessed April 30 2020.
32. Hosseinpoor Z, Farzanegan B, Seyyedi SR, Rajabi M, Baniasadi S. Drug
interactions and creatinine levels are associated with QTc prolongation
in intensive care units: A prospective, observational study. Drug Metab
Pers Ther. 2019; 34 :2-8.
33. Hydroxychloroquine - Azithromycin. Interactions. Lexicomp. Wolters
Kluwer Health, Inc. Riverwoods, IL. Available at:
http://online.lexi.com. Accessed April 30 2020.
34. Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and thrombotic or
thromboembolic disease: implications for prevention, antithrombotic
therapy, and follow-up. J Am Coll Cardiol. 2020. [Epub ahead of
print].
35. Vranckx P, Valgimigli M, Heidbuchel H. The significance of drug-drug
and drug-food interactions of oral anticoagulation. Arrhythmia
Electrophysiol Rev. 2018; 7: 55-61.
36. Delaney JA, Opatrny L, Brophy JM, Suissa S. Drug–drug interactions
between antithrombotic medications and the risk of gastrointestinal
bleeding. CMAJ. 2007;177:347-351.
37. Coronavirus disease 2019 (COVID-19) - Diagnosis and treatment - Mayo
Clinic.
https://www.mayoclinic.org/diseases-conditions/coronavirus/diagnosis-treatment/drc-20479976.
Accessed May 21, 2020.
38. Amici C, Di Caro A, Ciucci A, et al. Indomethacin has a potent
antiviral activity against SARS coronavirus. Antivir Ther. 2006; 11:
1021-1030.
39. Lopinavir and Ritonavir - Salmeterol. Interactions. Lexicomp.
Wolters Kluwer Health, Inc. Riverwoods, IL. Available at:
http://online.lexi.com. Accessed April 30 2020.
40. Flomax (tamsulosin) [prescribing information].
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020579s026lbl.pdf.
Accessed May 21, 2020.
Table 1 Demographic and clinical characteristics of the patients